Steve Pakola

Company: REGENXBIO
Job title: Chief Medical Officer
Seminars:
Utilizing Gene Therapy to Induce Long-Term Treatment of Wet AMD & Diabetic Retinopathy 10:05 am
Outline the RGX-314 gene therapy program Discussing why suprachoroidal/subretinal delivery are optimal for this treatment Reviewing the current clinical data from Phase III clinical trialsRead more
day: Day One